Luminex Corporation has received CE marking for its new xTAG Gastrointestinal Pathogen Panel (GPP).This innovative assay is the first test of its kind to help identify up to 95 percent of the disease causing pathogens in a single test. It delivers the highest number of relevant answers per sample in time to positively affect patient care.

As the most comprehensive test available to diagnose gastrointestinal infections, xTAG GPP simultaneously detects fifteen of the most common disease-causing pathogens, including viral, bacterial and parasitic infections, such as E. coli, Campylobacter, Salmonella and C. difficile. Providing accurate and timely identification of causative pathogens ultimately leads to improved health care outcomes and reduced costs. Additionally, the fast turn-around time and simultaneous testing on a single sample enable laboratories to better utilize their time and resources.